SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sun Healthcare [SHG] -- Ignore unavailable to you. Want to Upgrade?

To: John Pitera who wrote (17)2/2/1999 3:22:00 PM
From: E.J. Neitz Jr  Respond to of 39
 
John, They are debt heavy. Selling certainly related to bankrupcy fears precipitated by the debt load. It is critical that the company gets lenders to modify their loan covenants very quickly--if they do--stock could zoom upward. In my opinion thats the key.



To: John Pitera who wrote (17)2/4/1999 10:50:00 AM
From: s martin  Respond to of 39
 
I would be interested in your evaluation after reading the 10Q. Value Line reports book value as $17, I believe.



To: John Pitera who wrote (17)2/25/1999 3:20:00 PM
From: s martin  Read Replies (3) | Respond to of 39
 
"Edward, I'm thinking of buying some here, but I'm going to go over the 10Q I know they are loaded up on Debt. The question is can they sell assets and survive???"

SHG is at a new low, any thoughts as to whether it may be a buy at this point ?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News